Literature DB >> 10724825

Control of intraocular inflammation associated with cataract surgery.

A Z McColgin1, J S Heier.   

Abstract

Major advances in cataract extraction techniques and instrumentation have occurred over the past decade. Smaller incisions, more efficient phacoemulsifiers, and decreased surgical times are a few of the changes that have helped to alleviate postoperative inflammation, but postoperative inflammation continues to be a cause of patient discomfort; delayed recovery; and, in some cases, suboptimal visual results secondary to cystoid macular edema. This article reviews the most recent literature regarding the control of intraocular inflammation associated with cataract surgery.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10724825     DOI： 10.1097/00055735-200002000-00002

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN： 1040-8738            Impact factor:   3.761


  22 in total

1.  Comparison of Preoperative Topical Dexamethasone Phosphate Versus Ketorolac Tromethamine in Maintaining Intraoperative Mydriasis During Small Incision Cataract Surgery.

Authors:  Ashok Kumar Sharma; Hans Raj Sharma; Rajni Sharma; Amrita Singh
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation.

Authors:  L David Waterbury; Danielle Galindo; Linda Villanueva; Cathy Nguyen; Milan Patel; Lisa Borbridge; Mayssa Attar; Rhett M Schiffman; David A Hollander
Journal:  J Ocul Pharmacol Ther       Date:  2011-02-25       Impact factor: 2.671

3.  Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.

Authors:  Mahbubul H Shihan; Samuel G Novo; Melinda K Duncan
Journal:  Curr Med Res Opin       Date:  2019-08-28       Impact factor: 2.580

4.  Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.

Authors:  Nicola Cardascia; Carmela Palmisano; Tersa Centoducati; Giovanni Alessio
Journal:  Int Ophthalmol       Date:  2016-10-20       Impact factor: 2.031

5.  Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution.

Authors:  Hyung Cho; Kenneth J Wolf; Eric J Wolf
Journal:  Clin Ophthalmol       Date:  2009-06-02

Review 6.  Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.

Authors:  Viral V Juthani; Elizabeth Clearfield; Roy S Chuck
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

Review 7.  Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.

Authors:  Michael Amon; Massimo Busin
Journal:  Int Ophthalmol       Date:  2012-06-16       Impact factor: 2.031

8.  Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components.

Authors:  Mingli Qu; Yao Wang; Lingling Yang; Qingjun Zhou
Journal:  Mol Vis       Date:  2011-12-06       Impact factor: 2.367

9.  Etiology and treatment of the inflammatory causes of cystoid macular edema.

Authors:  Hyung Cho; Assumpta Madu
Journal:  J Inflamm Res       Date:  2009-10-02

10.  Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.

Authors:  Raymond Fong; Martin Leitritz; Raphaele Siou-Mermet; Tara Erb
Journal:  Clin Ophthalmol       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.